Senate confirms Hahn as FDA commissioner
December 13, 2019 -- The U.S. Senate has confirmed the Trump administration's nomination of radiation oncologist Dr. Stephen Hahn as commissioner of the U.S. Food and Drug Administration (FDA).
CAP deems surprise billing deal 'unacceptable'
December 11, 2019 -- The just-announced legislative proposal to use benchmark payment rates based on median or mean in-network contracts for out-of-network physician billing -- or so-called surprise billing -- is "unacceptable," the College of American Pathologists (CAP) said in a statement.
VA endorses AI research with new institute
December 9, 2019 -- The U.S. Department of Veterans Affairs (VA) has set up a new institute, the National Artificial Intelligence Institute, dedicated to advancing artificial intelligence (AI) research that might be meaningful to veterans and the public.
U.K. vitamin D study feeds into global debates on appropriate use
December 5, 2019 -- Prescriptions for vitamin D to U.K. children have risen dramatically over the years, and medical records suggest inappropriate use, according to a study published online December 3 in BMJ Open. The results feed into international debates about overuse and the high costs of supplementation and testing.  Discuss
FDA clears Roche's novel MRSA nasal swab test
December 5, 2019 -- The U.S. Food and Drug Administration (FDA) has given the green light to Roche Molecular Systems to market a new test based on bacterial viability and novel technology for detecting methicillin-resistant Staphylococcus aureus (MRSA) bacterial colonization, a common cause of hospital-acquired infections.
Philips, Paige join forces on AI and digital pathology
December 5, 2019 -- Philips Healthcare and Paige are joining to deliver artificial intelligence (AI) applications for cancer to pathology laboratories.
Nanomix mobile, 3-in-1 sepsis test gets CE Mark
December 5, 2019 -- Nanomix announced that its S1 assay for serious infections, including sepsis and bacteremia, has received the CE Mark, paving the way for sales in European markets in 2020.
High cost rules out NIPT as 1st test for Down syndrome
December 4, 2019 -- Noninvasive prenatal testing (NIPT) is better than conventional testing for Down syndrome, but its high cost must come down to make it more viable as a first-tier screening test, according to a Canadian study published on December 4 in PLOS One.  Discuss
FDA awards $20M to DNAnexus to enhance cloud-based research portal
December 4, 2019 -- The U.S. Food and Drug Administration (FDA) has awarded a five-year, $20 million contract to DNAnexus to build on its precisionFDA research and development cloud-based portal, which enables collaboration in validating next-generation sequencing technologies.
Smartphones double as point-of-care diagnostics
December 2, 2019 -- Smartphones are evolving into new point-of-care diagnostic tools, changing the way many common health conditions are diagnosed. Such devices can now compete with technology once thought to be restricted to physicians' offices and hospitals.  Discuss